Orphan drugs are a pharmaceutical agent that has been developed specifically to treat a rare medical condition. These are rare diseases classified strictly according to their prevalence, specifically “any disease or condition that affects 1 in 2500 in the EU”.
Milton Pharmaceutical Company are perfectly equipped to deliver an Orphan Drug molecule from pre-clinical and formulation development all the way to small scale commercialisation. As a small sized CDMO we are technically strong and creative in the development of solid oral, semi solids and liquid dosing.
Advantages of Using Milton Pharmaceutical Company For Your Orphan Drug Include:
- Working with small amounts of your API to handle your validation process.
- We can offer XcelolabTM to dose neat API into capsule
- Our set-up costs are low because the size of our business and our overheads
- Helping you with any registration and validation if and when required
We have experience in working with various Orphan Drugs companies and their API’s. We are a fee for service organisation and don’t hold any IP for any formulation of drug delivery platform that we use – these will remain with our clients.